This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2020 Dec 31;383(27):2652-2664.

doi: 10.1056/NEJMra2002697.

Pathophysiology of Inflammatory Bowel Diseases

Affiliations

Affiliation

¹ From the Department of Medicine, University of California San Diego, La Jolla, and the Department of Medicine, Veterans Affairs San Diego Healthcare System, San Diego.

PMID: 33382932
DOI: 10.1056/NEJMra2002697

Review

Pathophysiology of Inflammatory Bowel Diseases

John T Chang. N Engl J Med. 2020.

. 2020 Dec 31;383(27):2652-2664.

doi: 10.1056/NEJMra2002697.

Author

Affiliation

¹ From the Department of Medicine, University of California San Diego, La Jolla, and the Department of Medicine, Veterans Affairs San Diego Healthcare System, San Diego.

PMID: 33382932
DOI: 10.1056/NEJMra2002697

No abstract available

PubMed Disclaimer

Comment in

Pathophysiology of Inflammatory Bowel Diseases.
Chen CJ, Hu H, Liao WT. Chen CJ, et al. N Engl J Med. 2021 Apr 8;384(14):1376-1377. doi: 10.1056/NEJMc2101562. N Engl J Med. 2021. PMID: 33826830 No abstract available.
Pathophysiology of Inflammatory Bowel Diseases.
Gaffney P, Gaffney R. Gaffney P, et al. N Engl J Med. 2021 Apr 8;384(14):1377. doi: 10.1056/NEJMc2101562. N Engl J Med. 2021. PMID: 33826831 No abstract available.
Pathophysiology of Inflammatory Bowel Diseases.
Mravec B. Mravec B. N Engl J Med. 2021 Apr 8;384(14):1377-1378. doi: 10.1056/NEJMc2101562. N Engl J Med. 2021. PMID: 33826832 No abstract available.

Similar articles

Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.
Bouguen G, Chevaux JB, Peyrin-Biroulet L. Bouguen G, et al. World J Gastroenterol. 2011 Feb 7;17(5):547-56. doi: 10.3748/wjg.v17.i5.547. World J Gastroenterol. 2011. PMID: 21350703 Free PMC article. Review.
Recipe for IBD: can we use food to control inflammatory bowel disease?
Witkowski M, Witkowski M, Gagliani N, Huber S. Witkowski M, et al. Semin Immunopathol. 2018 Feb;40(2):145-156. doi: 10.1007/s00281-017-0658-5. Epub 2017 Nov 9. Semin Immunopathol. 2018. PMID: 29124320 Free PMC article. Review.
Regulatory T cells as potential targets for immunotherapy in inflammatory bowel disease.
Strisciuglio C, van Deventer S. Strisciuglio C, et al. Immunotherapy. 2010 Nov;2(6):749-52. doi: 10.2217/imt.10.63. Immunotherapy. 2010. PMID: 21091105 No abstract available.
Inflammatory bowel disease.
Beglinger C. Beglinger C. Swiss Med Wkly. 2009 Sep 19;139(37-38):526. doi: 10.4414/smw.2009.12912. Swiss Med Wkly. 2009. PMID: 19852078 No abstract available.
Current perspectives in inflammatory bowel disease: stress response and autophagy, host-microbe mutualism, immune duality and plasticity, and early versus late disease.
Fiocchi C. Fiocchi C. Curr Opin Gastroenterol. 2010 Jul;26(4):299-301. doi: 10.1097/MOG.0b013e32833c114d. Curr Opin Gastroenterol. 2010. PMID: 20571383 No abstract available.

See all similar articles

Cited by

Integrating transcriptomics and proteomics to analyze the immune microenvironment of cytomegalovirus associated ulcerative colitis and identify relevant biomarkers.
Chen Y, Zheng Q, Wang H, Tang P, Deng L, Li P, Li H, Hou J, Li J, Wang L, Peng J. Chen Y, et al. BioData Min. 2024 Aug 27;17(1):26. doi: 10.1186/s13040-024-00382-0. BioData Min. 2024. PMID: 39192288 Free PMC article.
Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn's Disease.
Kwon Y, Kim ES, Kim YZ, Choe YH, Kim MJ. Kwon Y, et al. Biomedicines. 2022 Sep 23;10(10):2372. doi: 10.3390/biomedicines10102372. Biomedicines. 2022. PMID: 36289634 Free PMC article.
Innate Lymphoid Cells as Regulators of Epithelial Integrity: Therapeutic Implications for Inflammatory Bowel Diseases.
Schulz-Kuhnt A, Neurath MF, Wirtz S, Atreya I. Schulz-Kuhnt A, et al. Front Med (Lausanne). 2021 Mar 30;8:656745. doi: 10.3389/fmed.2021.656745. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33869257 Free PMC article. Review.
Heart failure associated with ustekinumab therapy for treatment of Crohn's Disease.
Morgenweck E, Park B, Bower R. Morgenweck E, et al. BMJ Case Rep. 2022 Sep 20;15(9):e250376. doi: 10.1136/bcr-2022-250376. BMJ Case Rep. 2022. PMID: 36127033 Free PMC article.
P2X7 receptor as the regulator of T-cell function in intestinal barrier disruption.
Jiang ZF, Wu W, Hu HB, Li ZY, Zhong M, Zhang L. Jiang ZF, et al. World J Gastroenterol. 2022 Sep 28;28(36):5265-5279. doi: 10.3748/wjg.v28.i36.5265. World J Gastroenterol. 2022. PMID: 36185635 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- H1 Connect
- The Lens - Patent Citations Database